Zybrestat fosbretabulin: Completed Phase II enrollment

OxiGene completed enrollment of 60 patients in the open-label, U.S. Phase II FALCON trial evaluating Avastin bevacizumab and carboplatin/paclitaxel with or without IV Zybrestat. Roche (SWX:ROG; OTCQ...